These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1320976)

  • 1. Effects of camptothecin, an inhibitor of DNA topoisomerase I on ribosomal gene structure and function in TG cells.
    Farabegoli F; Govoni M; Novello F
    Biol Cell; 1992; 74(3):281-6. PubMed ID: 1320976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes.
    Zhang H; Wang JC; Liu LF
    Proc Natl Acad Sci U S A; 1988 Feb; 85(4):1060-4. PubMed ID: 2829214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct effects of topoisomerase I and RNA polymerase I inhibitors suggest a dual mechanism of nucleolar/nucleoplasmic partitioning of topoisomerase I.
    Christensen MO; Krokowski RM; Barthelmes HU; Hock R; Boege F; Mielke C
    J Biol Chem; 2004 May; 279(21):21873-82. PubMed ID: 15014084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of topoisomerase II activity and its effect on nucleolar structure and function.
    Govoni M; Farabegoli F; Pession A; Novello F
    Exp Cell Res; 1994 Mar; 211(1):36-41. PubMed ID: 7510250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of RNA polymerase II transcription causes chromatin decondensation, loss of nucleolar structure, and dispersion of chromosomal domains.
    Haaf T; Ward DC
    Exp Cell Res; 1996 Apr; 224(1):163-73. PubMed ID: 8612682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of ribosomal RNA synthesis in a gene dosage mutant: the relationship of topoisomerase I and chromatin structure to transcriptional activity.
    Muscarella DE; Vogt VM; Bloom SE
    J Cell Biol; 1987 Oct; 105(4):1501-13. PubMed ID: 2822724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note.
    Kaufmann SH
    Cancer Res; 1989 Nov; 49(21):5870-8. PubMed ID: 2790800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of DNA topoisomerase I in the transcription of supercoiled rRNA gene.
    Garg LC; DiAngelo S; Jacob ST
    Proc Natl Acad Sci U S A; 1987 May; 84(10):3185-8. PubMed ID: 3033639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unusual perinucleolar accumulation of ribonucleoprotein granules induced by camptothecin in isolated liver cells.
    Gajkowska B; Puvion E; Bernhard W
    J Ultrastruct Res; 1977 Sep; 60(3):335-47. PubMed ID: 894779
    [No Abstract]   [Full Text] [Related]  

  • 10. Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and II inhibitors.
    Bertrand R; Solary E; Jenkins J; Pommier Y
    Exp Cell Res; 1993 Aug; 207(2):388-97. PubMed ID: 7688316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructural nucleolar alterations induced by an ametantrone--poly r(A-U) complex.
    Jamison JM; Gilloteaux J; Thiry M; Authelet M; Goessens G; Summers JL
    Tissue Cell; 1998 Aug; 30(4):475-84. PubMed ID: 9787478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-selective effects of nucleolar stress and rDNA damage in developmental disorders.
    Calo E; Gu B; Bowen ME; Aryan F; Zalc A; Liang J; Flynn RA; Swigut T; Chang HY; Attardi LD; Wysocka J
    Nature; 2018 Feb; 554(7690):112-117. PubMed ID: 29364875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sites of topoisomerase I action on X. laevis ribosomal chromatin: transcriptionally active rDNA has an approximately 200 bp repeating structure.
    Culotta V; Sollner-Webb B
    Cell; 1988 Feb; 52(4):585-97. PubMed ID: 2830030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleolar activation during artificial demethylation of DNA in cultured pig embryonic kidney cells.
    Zatsepina OV; Airapetyan VO; Kir'yanov GI
    Biomed Sci; 1990; 1(5):487-93. PubMed ID: 1723004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines.
    Goldwasser F; Bae I; Fornace AJ; Pommier Y
    Oncol Res; 1996; 8(7-8):317-23. PubMed ID: 8938795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ribosome formation is blocked by camptothecin, a reversible inhibitor of RNA synthesis.
    Wu RS; Kumar A; Warner JR
    Proc Natl Acad Sci U S A; 1971 Dec; 68(12):3009-14. PubMed ID: 5289246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and functional organization of ribosomal genes within the mammalian cell nucleolus.
    Derenzini M; Pasquinelli G; O'Donohue MF; Ploton D; Thiry M
    J Histochem Cytochem; 2006 Feb; 54(2):131-45. PubMed ID: 16204224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of DNA damage, inhibition of DNA synthesis, and suppression of c-myc expression by the topoisomerase I inhibitor, camptothecin, in MCF-7 human breast tumor cells.
    Jain PT; Fornari FA; Randolph JK; Orr MS; Gewirtz DA
    Biochem Pharmacol; 1998 Apr; 55(8):1263-9. PubMed ID: 9719482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation induction of human promyelocytic leukemia cells by 10-hydroxycamptothecin, a DNA topoisomerase I inhibitor.
    Ling YH; Tseng MT; Nelson JA
    Differentiation; 1991 Mar; 46(2):135-41. PubMed ID: 1648523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoid-induced stimulation of ribosomal gene transcription in rat hepatoma cells is mediated by modification of RNA polymerase I or an associated factor.
    Webb ML; Mealey-Cavender JF; Jacob ST
    Mol Endocrinol; 1989 Nov; 3(11):1861-8. PubMed ID: 2608060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.